Shares of GPU titan Nvidia (NASDAQ:NVDA) may have been stuck in a sideways channel for the past six months, but a lot has ...

At the JP Morgan Healthcare conference this year, a lot of the discourse around AI drug discovery focused on making the leap ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...

The companies will invest up to $1 billion over five years to support discovery and development powered by artificial ...

Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...

More biopharma organizations were actively recruiting at the end of 2025 than 2024, based on the new BioSpace employment ...

Prism aims to move ChatGPT into scientific writing as OpenAI signals plans to share in future profits. Some are warning against its pitfalls.

FAR Biotech, a computational drug discovery company, has officially relocated to Wisconsin. The move marks a significant ...

Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative ...

When pursuing a single drug candidate, chemists make many molecules. Pharmaceutical companies catalog and store these ...

Florida State University is looking to participate in what could be a groundbreaking drug discovery study through a ...